Experiment: 8FTW

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-15N HSQC	400 uM [U-100% 15N], 100% 13C-CH3_ILVMAT, 100%-1H,13C-Phe,Tyr FliT_1-95-FliJ_51-101_fusion, 20 mM potassium phosphate, 100 mM potassium chloride, 0.05 % sodium azide, 5 mM beta-mercaptoethanol	95% H2O/5% D2O	200 mM	7.0	1 atm	25	Bruker AVANCE 850
2	2D 1H-13C HSQC	400 uM [U-100% 15N], 100% 13C-CH3_ILVMAT, 100%-1H,13C-Phe,Tyr FliT_1-95-FliJ_51-101_fusion, 20 mM potassium phosphate, 100 mM potassium chloride, 0.05 % sodium azide, 5 mM beta-mercaptoethanol	95% H2O/5% D2O	200 mM	7.0	1 atm	25	Bruker AVANCE 850
3	3D HNCACB	400 uM [U-13C; U-15N; U-2H] FliT_1-95-FliJ_51-101_fusion, 20 mM potassium phosphate, 100 mM potassium chloride, 0.05 % sodium azide, 5 mM beta-mercaptoethanol	95% H2O/5% D2O	200 mM	7.0	1 atm	25	Bruker AVANCE 700
4	3D HNCO	400 uM [U-13C; U-15N; U-2H] FliT_1-95-FliJ_51-101_fusion, 20 mM potassium phosphate, 100 mM potassium chloride, 0.05 % sodium azide, 5 mM beta-mercaptoethanol	95% H2O/5% D2O	200 mM	7.0	1 atm	25	Bruker AVANCE 700
5	3D HN(COCA)CB	400 uM [U-13C; U-15N; U-2H] FliT_1-95-FliJ_51-101_fusion, 20 mM potassium phosphate, 100 mM potassium chloride, 0.05 % sodium azide, 5 mM beta-mercaptoethanol	95% H2O/5% D2O	200 mM	7.0	1 atm	25	Bruker AVANCE 700
17	3D 1H-13C NOESY	400 uM [U-100% 15N], 100% 13C-CH3_ILVMAT, 100%-1H,13C-Phe,Tyr FliT_1-95-FliJ_51-101_fusion, 20 mM potassium phosphate, 100 mM potassium chloride, 0.05 % sodium azide, 5 mM beta-mercaptoethanol	95% H2O/5% D2O	200 mM	7.0	1 atm	25	Bruker AVANCE 850
16	3D 1H-13C NOESY aromatic	400 uM [U-100% 15N], 100% 13C-CH3_ILVMAT, 100%-1H,13C-Phe,Tyr FliT_1-95-FliJ_51-101_fusion, 20 mM potassium phosphate, 100 mM potassium chloride, 0.05 % sodium azide, 5 mM beta-mercaptoethanol	95% H2O/5% D2O	200 mM	7.0	1 atm	25	Bruker AVANCE 850
15	3D 1H-15N NOESY	400 uM [U-100% 15N], 100% 13C-CH3_ILVMAT, 100%-1H,13C-Phe,Tyr FliT_1-95-FliJ_51-101_fusion, 20 mM potassium phosphate, 100 mM potassium chloride, 0.05 % sodium azide, 5 mM beta-mercaptoethanol	95% H2O/5% D2O	200 mM	7.0	1 atm	25	Bruker AVANCE 850
14	2D 1H-15N HSQC	400 uM [U-13C; U-15N; U-2H] FliT_1-95-FliJ_51-101_fusion, 20 mM potassium phosphate, 100 mM potassium chloride, 0.05 % sodium azide, 5 mM beta-mercaptoethanol	95% H2O/5% D2O	200 mM	7.0	1 atm	25	Bruker AVANCE 700
13	3D 1H-15N NOESY	400 uM [U-13C; U-15N; U-2H] FliT_1-95-FliJ_51-101_fusion, 20 mM potassium phosphate, 100 mM potassium chloride, 0.05 % sodium azide, 5 mM beta-mercaptoethanol	95% H2O/5% D2O	200 mM	7.0	1 atm	25	Bruker AVANCE 700

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE	700
2	Bruker	AVANCE	850

NMR Refinement
Method	Details	Software
molecular dynamics	MD in explicit H2O	CNS

NMR Ensemble Information
Conformer Selection Criteria	target function
Conformers Calculated Total Number	100
Conformers Submitted Total Number	20
Representative Model	1 (lowest energy)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	refinement	CNS		Brunger, Adams, Clore, Gros, Nilges and Read
8	collection	TopSpin		Bruker Biospin
7	processing	NMRPipe		Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax
6	geometry optimization	TALOS		Cornilescu, Delaglio and Bax
5	processing	PdbStat		tejero & montelione
2	structure calculation	CYANA	3.98	Guntert, Mumenthaler and Wuthrich
3	chemical shift assignment	PINE		Bahrami, Markley, Assadi, and Eghbalnia
4	peak picking	Sparky		Goddard

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.